Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases

Journal of Immunology

Volumn 192, Issue 6, 2014, Pages 2551-2563

  Han, Sungpil ^a,b   Lin, Yen Chih ^a   Wu, Tianxia ^a   Salgado, Alan D ^a   Mexhitaj, Ina ^a   Wuest, Simone C ^a   Romm, Elena ^a   Ohayon, Joan ^a   Goldbach Mansky, Raphaela ^c   Vanderver, Adeline ^d   Marques, Adriana ^e   Toro, Camilo ^f   Williamson, Peter ^e   Cortese, Irene ^a   Bielekova, Bibiana ^a,g  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b Pusan National University School of Medicine   (South Korea)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD56 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; AICARDI GOUTIERES SYNDROME; ARTICLE; B LYMPHOCYTE ACTIVATION; BASOPHIL; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL SIZE; CELLULAR IMMUNITY; CEREBROSPINAL FLUID CYTOLOGY; CINCA SYNDROME; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GRANULOCYTE FUNCTION; HUMAN; HUMAN CELL; IMMUNE CELL FUNCTION ASSAY; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INNATE IMMUNITY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MEASUREMENT ACCURACY; MEMORY T LYMPHOCYTE; MONOCYTE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUROIMMUNOLOGICAL DISEASE; NEUROLOGIC DISEASE; PHENOTYPIC VARIATION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD56; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CELL COUNT; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INFLAMMATION; KILLER CELLS, NATURAL; LEUKOCYTES; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NERVOUS SYSTEM MALFORMATIONS; PROSPECTIVE STUDIES; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84897560960     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302884     Document Type: Article

References (58)

1. Lucchinetti, C. F., W. Brück, M. Rodriguez, and H. Lassmann. 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6: 259-274.
2. Miller, D. H., and S. M. Leary. 2007. Primary-progressive multiple sclerosis. Lancet Neurol. 6: 903-912.
3. Mahad, D., H. Lassmann, and D. Turnbull. 2008. Review: mitochondria and disease progression in multiple sclerosis. Neuropathol. Appl. Neurobiol. 34: 577-589.
4. Sastre-Garriga, J., G. T. Ingle, D. T. Chard, M. Cercignani, L. Ramió-Torrentà, D. H. Miller, and A. J. Thompson. 2005. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain 128: 1454-1460.
5. Lucchinetti, C., and W. Bruck. 2004. The pathology of primary progressive multiple sclerosis. Mult. Scler. 10(Suppl. 1): S23-S30.
6. Choi, S. R., O. W. Howell, D. Carassiti, R. Magliozzi, D. Gveric, P. A. Muraro, R. Nicholas, F. Roncaroli, and R. Reynolds. 2012. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain 135: 2925-2937.
7. Androdias, G., R. Reynolds, M. Chanal, C. Ritleng, C. Confavreux, and S. Nataf. 2010. Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann. Neurol. 68: 465-476.
8. Magliozzi, R., O. W. Howell, C. Reeves, F. Roncaroli, R. Nicholas, B. Serafini, F. Aloisi, and R. Reynolds. 2010. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann. Neurol. 68: 477-493.
9. Hawker, K., P. O'Connor, M. S. Freedman, P. A. Calabresi, J. Antel, J. Simon, S. Hauser, E. Waubant, T. Vollmer, H. Panitch, et al; OLYMPUS trial group. 2009. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann. Neurol. 66: 460-471.
10. Almeida de Jesus, A., and R. Goldbach-Mansky. 2013. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin. Immunol. 147: 155-174.
11. Cepok, S., M. Jacobsen, S. Schock, B. Omer, S. Jaekel, I. Böddeker, W. H. Oertel, N. Sommer, and B. Hemmer. 2001. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124: 2169-2176.
12. Krumbholz, M., D. Theil, S. Cepok, B. Hemmer, P. Kivisäkk, R. M. Ransohoff, M. Hofbauer, C. Farina, T. Derfuss, C. Hartle, et al. 2006. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129: 200-211.
13. Kowarik, M. C., S. Cepok, J. Sellner, V. Grummel, M. S. Weber, T. Korn, A. Berthele, and B. Hemmer. 2012. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J. Neuroinflammation 9: 93.
14. Cepok, S., B. Rosche, V. Grummel, F. Vogel, D. Zhou, J. Sayn, N. Sommer, H. P. Hartung, and B. Hemmer. 2005. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128: 1667-1676.
15. Kuenz, B., A. Lutterotti, R. Ehling, C. Gneiss, M. Haemmerle, C. Rainer, F. Deisenhammer, M. Schocke, T. Berger, and M. Reindl. 2008. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS ONE 3: e2559.
16. Pashenkov, M., Y. M. Huang, V. Kostulas, M. Haglund, M. Söderström, and H. Link. 2001. Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124: 480-492.
17. Longhini, A. L., F. von Glehn, C. O. Brandão, R. F. de Paula, F. Pradella, A. S. Moraes, A. S. Farias, E. C. Oliveira, J. G. Quispe-Cabanillas, C. H. Abreu, et al. 2011. Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse. J. Neuroinflammation 8: 2.
18. Heinrich, A., N. Ahrens, S. Schmidt, and A. V. Khaw. 2006. Immunophenotypic patterns of T-cell activation in neuroinflammatory diseases. Acta Neurol. Scand. 113: 248-255.
19. Scolozzi, R., A. Boccafogli, M. R. Tola, L. Vicentini, A. Camerani, D. Degani, E. Granieri, L. Caniatti, and E. Paolino. 1992. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. J. Neurol. Sci. 108: 93-98.
20. de Graaf, M. T., P. A. Smitt, R. L. Luitwieler, C. van Velzen, P. D. van den Broek, J. Kraan, and J. W. Gratama. 2011. Central memory CD4+ T cells dominate the normal cerebrospinal fluid. Cytometry B Clin. Cytom. 80: 43-50.
21. Polman, C. H., S. C. Reingold, B. Banwell, M. Clanet, J. A. Cohen, M. Filippi, K. Fujihara, E. Havrdova, M. Hutchinson, L. Kappos, et al. 2011. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69: 292-302.
22. Bielekova, B., M. Catalfamo, S. Reichert-Scrivner, A. Packer, M. Cerna, T. A. Waldmann, H. McFarland, P. A. Henkart, and R. Martin. 2006. Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103: 5941-5946.
23. Stüve, O., C. M. Marra, A. Bar-Or, M. Niino, P. D. Cravens, S. Cepok, E. M. Frohman, J. T. Phillips, G. Arendt, K. R. Jerome, et al. 2006. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch. Neurol. 63: 1383-1387.
24. Chofflon, M., V. González, H. L. Weiner, and D. A. Hafler. 1989. Inflammatory cerebrospinal fluid T cells have activation requirements characteristic of CD4+ CD45RA2 T cells. Eur. J. Immunol. 19: 1791-1795.
25. Kawakami, N., U. V. Nägerl, F. Odoardi, T. Bonhoeffer, H. Wekerle, and A. Flügel. 2005. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J. Exp. Med. 201: 1805-1814.
26. Grundtner, R., K. Dornmair, R. Dahm, A. Flügel, N. Kawakami, M. Zeitelhofer, L. Schoderboeck, M. Nosov, E. Selzer, M. Willheim, et al. 2007. Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system. Neurobiol. Dis. 28: 261-275.
27. Becker, K. J. 2012. Activation of immune responses to brain antigens after stroke. J. Neurochem. 123(Suppl. 2): 148-155.
28. Kim, J. V., S. S. Kang, M. L. Dustin, and D. B. McGavern. 2009. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457: 191-195.
29. Kotter, M. R., C. Zhao, N. van Rooijen, and R. J. Franklin. 2005. Macrophagedepletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 18: 166-175.
30. Ruckh, J. M., J. W. Zhao, J. L. Shadrach, P. van Wijngaarden, T. N. Rao, A. J. Wagers, and R. J. Franklin. 2012. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10: 96-103.
31. Miron, V. E., A. Boyd, J. W. Zhao, T. J. Yuen, J. M. Ruckh, J. L. Shadrach, P. van Wijngaarden, A. J. Wagers, A. Williams, R. J. Franklin, and C. ffrench-Constant. 2013. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16: 1211-1218.
32. Hislop, A. D., G. S. Taylor, D. Sauce, and A. B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25: 587-617.
33. Stohlman, S. A., D. R. Hinton, B. Parra, R. Atkinson, and C. C. Bergmann. 2008. CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus. J. Virol. 82: 2130-2139.
34. Donaghy, H., L. Bosnjak, A. N. Harman, V. Marsden, S. K. Tyring, T. C. Meng, and A. L. Cunningham. 2009. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 83: 1952-1961.
35. Kim, M., N. R. Osborne, W. Zeng, H. Donaghy, K. McKinnon, D. C. Jackson, and A. L. Cunningham. 2012. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. J. Immunol. 188: 4158-4170.
36. Chew, T., K. E. Taylor, and K. L. Mossman. 2009. Innate and adaptive immune responses to herpes simplex virus. Viruses 1: 979-1002.
37. Bettelli, E., D. Baeten, A. Jäger, R. A. Sobel, and V. K. Kuchroo. 2006. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Deviclike disease in mice. J. Clin. Invest. 116: 2393-2402.
38. Krishnamoorthy, G., H. Lassmann, H. Wekerle, and A. Holz. 2006. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116: 2385-2392.
39. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al; HERMES Trial Group. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688.
40. Babbe, H., A. Roers, A. Waisman, H. Lassmann, N. Goebels, R. Hohlfeld, M. Friese, R. Schröder, M. Deckert, S. Schmidt, et al. 2000. Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
41. Tsakiri, A., E. Kjærsgaard, N. Grigoriadis, I. M. Svane, and J. L. Frederiksen. 2012. Effector and regulatory T cells in patients with acute optic neuritis. Neuroimmunomodulation 19: 111-120.
42. Fritzsching, B., J. Haas, F. König, P. Kunz, E. Fritzsching, J. Pöschl, P. H. Krammer, W. Brück, E. Suri-Payer, and B. Wildemann. 2011. Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. PLoS ONE 6: e17988.
43. Cross, A. H., J. L. Trotter, and J. Lyons. 2001. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112: 1-14.
44. Krumbholz, M., D. Theil, T. Derfuss, A. Rosenwald, F. Schrader, C. M. Monoranu, S. L. Kalled, D. M. Hess, B. Serafini, F. Aloisi, et al. 2005. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201: 195-200.
45. Sellebjerg, F., L. Börnsen, M. Khademi, M. Krakauer, T. Olsson, J. L. Frederiksen, and P. S. Sørensen. 2009. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 73: 2003-2010.
46. Bielekova, B., M. Komori, Q. Xu, D. S. Reich, and T. Wu. 2012. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation. PLoS ONE 7: e48370.
47. Sedimbi, S. K., T. Hägglöf, and M. C. Karlsson. 2013. IL-18 in inflammatory and autoimmune disease. Cell. Mol. Life Sci. 70: 4795-4808.
48. Crow, Y. J. 2013. Aicardi-Goutiéres syndrome. Handb. Clin. Neurol. 113: 1629-1635.
49. Crow, Y. J., and J. Rehwinkel. 2009. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum. Mol. Genet. 18(R2): R130-R136.
50. Reizis, B., A. Bunin, H. S. Ghosh, K. L. Lewis, and V. Sisirak. 2011. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29: 163-183.
51. Ho, E. L., R. Ronquillo, H. Altmeppen, S. S. Spudich, R. W. Price, and E. Sinclair. 2013. Cellular composition of cerebrospinal fluid in HIV-1 infected and uninfected subjects. PLoS ONE 8: e66188.
52. Amanna, I. J., N. E. Carlson, and M. K. Slifka. 2007. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357: 1903-1915.
53. Landis, S. C., S. G. Amara, K. Asadullah, C. P. Austin, R. Blumenstein, E. W. Bradley, R. G. Crystal, R. B. Darnell, R. J. Ferrante, H. Fillit, et al. 2012. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490: 187-191.
54. Kuehne, L. K., H. Reiber, K. Bechter, L. Hagberg, and D. Fuchs. 2013. Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders. J. Psychiatr. Res. 47: 1417-1422.
55. Pranzatelli, M. R., E. D. Tate, N. R. McGee, A. L. Travelstead, J. A. Colliver, J. M. Ness, and R. M. Ransohoff. 2013. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. J. Neuroinflammation 10: 10.
56. von Büdingen, H. C., T. C. Kuo, M. Sirota, C. J. van Belle, L. Apeltsin, J. Glanville, B. A. Cree, P. A. Gourraud, A. Schwartzburg, G. Huerta, et al. 2012. B cell exchange across the blood-brain barrier in multiple sclerosis. J. Clin. Invest. 122: 4533-4543.
57. Lovato, L., S. N. Willis, S. J. Rodig, T. Caron, S. E. Almendinger, O. W. Howell, R. Reynolds, K. C. O'Connor, and D. A. Hafler. 2011. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain 134: 534-541.
58. Ioannidis, J. P. 2005. Why most published research findings are false. PLoS Med. 2: e124.